Lucas Moreno is a paediatric oncologist dedicated to early clinical trials and neuroblastoma. He is the main investigator of a trial co-financed by Imagine for Margo : BEACON.
He trained in La Fe (Valencia, Spain), started his career in the Royal Marsden Hospital (London, UK) under the mentorship of Andy Pearson and from 2013, he leads the Clinical Trials Unit at Hospital Niño Jesus in Madrid, Spain. He is an active member of European consortia for neuroblastoma (SIOPEN) and early clinical trials (ITCC) and he leads the BEACON-Neuroblastoma European trial for relapsed and refractory neuroblastoma. His research interests are predictive and pharmacodynamic biomarkers, neuroblastoma drug development and clinical trial methodology.
